Compare JOUT & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JOUT | LXRX |
|---|---|---|
| Founded | 1970 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 486.7M | 660.9M |
| IPO Year | 1994 | 2000 |
| Metric | JOUT | LXRX |
|---|---|---|
| Price | $49.48 | $1.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.15 |
| AVG Volume (30 Days) | 75.5K | ★ 2.3M |
| Earning Date | 05-01-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.55% | N/A |
| EPS Growth | N/A | ★ 77.78 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $592,415,000.00 | $49,803,000.00 |
| Revenue This Year | $11.67 | N/A |
| Revenue Next Year | $3.70 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 60.24 |
| 52 Week Low | $21.48 | $0.49 |
| 52 Week High | $53.01 | $1.86 |
| Indicator | JOUT | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 54.53 | 62.01 |
| Support Level | $42.87 | $1.07 |
| Resistance Level | $51.34 | N/A |
| Average True Range (ATR) | 2.15 | 0.10 |
| MACD | 0.37 | 0.02 |
| Stochastic Oscillator | 61.33 | 83.75 |
Johnson Outdoors Inc is a manufacturer and marketer of branded seasonal, outdoor recreation products used for fishing from a boat, diving, paddling, hiking and camping. The company has four operating segment: Fishing, Camping, Watercraft Recreation, and Diving. It generates maximum revenue from the Fishing segment which produces and markets products under different brands such as Minn Kota electric motors for quiet trolling or primary propulsion, marine battery chargers and shallow water anchors; Humminbird sonar and GPS equipment for fish finding, navigation and marine cartography; and Cannon downriggers for controlled-depth fishing. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe, Canada, and other regions.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.